Division of Nephrology and Kidney C.A.R.E. Program, University of Cincinnati, OH.
Department of Internal Medicine, University Hospital Knappschaftskrankenhaus Bochum, Ruhr-University Bochum, Bochum, Germany.
Adv Kidney Dis Health. 2023 Jul;30(4):315-335. doi: 10.1053/j.akdh.2023.04.001.
Nonalcoholic fatty liver disease is a multisystem condition with effects beyond the liver. The identification of chronic kidney disease as an independent mediator of nonalcoholic fatty liver disease or associated entity with shared cardiometabolic risk factors remains controversial and continues to draw scientific interest. With increasing prevalence of nonalcoholic fatty liver disease and lack of Food and Drug Administration approved therapies, these shared cardiometabolic risk factors have drawn significant attention. In this article, we review shared pathophysiological mechanisms between nonalcoholic fatty liver disease and chronic kidney disease along with current treatment strategies that might be useful for both disease processes.
非酒精性脂肪性肝病是一种多系统疾病,其影响超出肝脏。慢性肾脏病作为非酒精性脂肪性肝病或相关疾病的独立中介,其与共同的心血管代谢危险因素相关联,这一观点仍存在争议,并且持续引起科学界的兴趣。随着非酒精性脂肪性肝病患病率的增加和缺乏食品和药物管理局批准的治疗方法,这些共同的心血管代谢危险因素引起了广泛关注。在本文中,我们综述了非酒精性脂肪性肝病和慢性肾脏病之间共同的病理生理机制,以及可能对这两种疾病过程都有用的当前治疗策略。